Delivery Order 36F79724D0159-15B50526F00000184
Award Date 7/1/26
Potential Completion Date 9/30/26
Potential Value $95K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Titusville, Hopewell Township, NJ 08560, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Federal Medical Center Carswell issued a $19,234.80 delivery order to Actelion Pharmaceuticals US, Inc. on July 1, 2026, under the Pharmaceuticals and Drugs FSS-61-IB schedule for Veletri 1.5 mg for the period July through September 2026, with completion by September 30, 2026. The Pharmaceuticals and Drugs FSS-61-IB is a multiple-award Federal Supply Schedule contract enabling federal healthcare institutions to procure specialized pharmaceutical products at pre-negotiated pricing. Place of...
- Actelion Pharmaceuticals US, Inc. has been awarded a $19,535.58 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) managed by the General Services Administration. The order is for 1,600 microgram bottles of Uptravi to be provided to the Federal Bureau of Prisons' Federal Medical Center in Carswell, Texas by February 2029. The delivery order was issued without a set-aside designation by the Department of Justice Bureau of Prisons on February 2, 2024. Actelion...
- Actelion Pharmaceuticals US, Inc. has been awarded a firm fixed-price delivery order valued at $12.5M by the Federal Medical Center Carswell for an emergency procurement of Opsumit 10mg (quantity 2 at $6,270.03 each), with an ultimate completion date of December 3, 2025. This delivery order was issued without a small business set-aside designation and represents direct pharmaceutical procurement under the company's existing Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and...
- This federal contract award was issued by the Federal Medical Center Carswell, a civilian agency, to the prime contractor Actelion Pharmaceuticals US, Inc. The $72,226.86 fixed-price delivery order is for the procurement of various medications used to treat pulmonary arterial hypertension, including Opsumit, Uptravi, and Adempas. The contract does not utilize a small business set-aside. Actelion Pharmaceuticals US, Inc. is a for-profit pharmaceutical manufacturer that specializes in developing...
- The Department of Justice Bureau of Prisons Federal Medical Center Carswell awarded a $54,303.72 delivery order contract to Actelion Pharmaceuticals US, Inc. for the supply of 30-count bottles of the pulmonary hypertension drug Opsumit (macitentan) 10mg. Actelion will deliver the medication under a firm fixed price arrangement by December 30, 2023 in performance of the Master GSA Schedule contract Pharmaceuticals and Drugs (FSS-61-IB). As the largest federal medical center operated by the Bureau...
- Actelion Pharmaceuticals US, Inc. was awarded a $69,457.89 firm fixed price delivery order against its GSA Schedule Pharmaceuticals and Drugs contract to provide the Department of Justice Bureau of Prisons' Federal Medical Center in Carswell, Texas with the pulmonary arterial hypertension drugs CURASCRIPT and UPTRAVI. The contract has a period of performance from July 1, 2023 through September 15, 2023 for drug delivery to the facility in Lake Mary, Florida. No subcontractors or set aside...
- The Federal Correctional Institution Fort Worth awarded a delivery order valued at approximately $62K to Actelion Pharmaceuticals US, Inc. for pharmaceutical products Uptravi (selexipag) and Opsumit through a Firm Fixed Price contract with a completion date of May 31, 2026. This delivery order is a child contract issued under the parent Federal Supply Schedule 61-IB (Pharmaceuticals and Drugs) contract, which provides a streamlined procurement vehicle for federal agencies to order pre-negotiated...
- This delivery order against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 is for the drug UPTRAVI 1200MCG, with a potential value of $13,765.14. The prime contractor is Actelion Pharmaceuticals US, Inc. located in Titusville, New Jersey. The contract has a firm fixed price and is for delivery of the requested pharmaceutical to the agency's facilities, with performance at...
- Actelion Pharmaceuticals US, Inc. was awarded a $14,584.53 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price order is for the emergency provision of 1,600mcg doses of UPTRAVI to the Titusville, Hopewell Township, New Jersey VA medical center, with performance required by June 19, 2023. No set-aside designation was applied to...
- This is a Delivery Order awarded by the Department of Justice Bureau of Prisons Federal Medical Center Carswell to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical goods. The order is for CURASCRIPT, OPSUMIT 10MG 30-COUNT BOTTLES, with a potential value of $58,648.02. The contract has a completion date of March 31, 2024 and is placed against Actelion's existing Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs. This indicates Actelion is...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79724D0159Federal Supply Schedule
- 36F79724D0159-15B50526F00000184Delivery Order
Federal Medical Center Carswell issued a delivery order to Actelion Pharmaceuticals US, Inc. on July 1, 2026, for Uptravi pharmaceutical products with a ceiling value of $95,407.83, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price and calls against the parent GSA Federal Supply Schedule contract for Pharmaceuticals and Drugs, which provides access to specialized pharmaceutical products for federal healthcare institutions. Place of performance is Titusville, Hopewell Township, NJ. The order is due for ultimate completion on September 30, 2026. No set-aside applies to this delivery order.
Generated 7/16/26, 9:51 AM